Trial intelligence / Profile preview

Randomized phase II trial of idarubicin + etoposide with sequential or concurrent azacitidine and azacitidine maintenance in acute myeloid leukemia

2009-016142-44Phase 2Completed

Sponsor

University Hospital Ulm

Start

Jul 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1